Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Outcomes of Hepatitis C Virus...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Outcomes of Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir in Mongolian Population: Successes and Challenges Facing Scale-up of Care

Outcomes of Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir in Mongolian Population: Successes and Challenges Facing Scale-up of Care

Bibliographic Details
Main Authors: Seong Hee Kang, Moon Young Kim
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2021-01-01
Series:Clinical and Molecular Hepatology
Subjects:
hepatitis c, chronic
lediapsvir
sofosbuvir
Online Access:http://e-cmh.org/upload/pdf/cmh-2020-0312.pdf
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://e-cmh.org/upload/pdf/cmh-2020-0312.pdf

Similar Items

  • Treatment with ledipasvir-sofosbuvir for hepatitis C resulting in improvement of lichen planus
    by: Umer Ansari, BS, et al.
    Published: (2017-01-01)
  • Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
    by: Oidov Baatarkhuu, et al.
    Published: (2021-01-01)
  • Successful Treatment of Hepatitis C Virus by Ledipasvir/Sofosbuvir in a Cirrhotic Patient with Sickle Cell Disease and Thalassemia Minor
    by: Hassan Al Moussawi, et al.
    Published: (2018-10-01)
  • Ledipasvir and sofosbuvir for treatment of post- renal transplant hepatitis C infection: A case report withreview of literature
    by: R Jha, et al.
    Published: (2016-01-01)
  • Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients
    by: Mohammed A Babatin, et al.
    Published: (2019-01-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...